All Reports

Makary's exit creates new uncertainty at FDA

axios.comMay 13, 2026 at 12:02 PM4 views
C

Selective Omission

How They Deceive You

Propaganda

C

Notable spin via repeated framing of chaos and political interference as fact, unverified quotes, opaque analyst sourcing, and omission of administration praise and achievements.

Main Device

Selective Omission

Omits HHS Secretary RFK Jr.'s praise and Makary's 20+ reforms like biosimilars acceleration, creating an unbalanced portrait of failure and upheaval.

Archetype

Pro-establishment regulatory defender

Champions FDA's 'predictability and evidence-based' past while portraying Trump-era changes as disruptive interference favoring chaos over stability.

This article deceives by framing Makary's tenure as chaotic controversy through unverified claims, critic quotes, and omissions of praise and reforms.

Writer's Worldview

Pro-establishment regulatory defender

8 findings · 4 omissions · 5 sources compared

What is your news hiding from you?

Same analysis. Any article. Try free for 7 days.

Now check your news

You just saw what we found in this article. Paste any URL and get the same analysis — the propaganda, the missing context, and the spin.

7 days free · $4.99/mo after